Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori

NCT03087162 PHASE4 COMPLETED

New drug regimen for Helicobacter pylori eradication, the investigators compare once daily dose dexlansoprazole levofloxacin based quadruple therapy and twice daily dose dexlansoprazole levofloxacin quadruple therapy for helicobacter pylori eradication.

Details

Lead sponsor	Ramathibodi Hospital
Phase	PHASE4
Status	COMPLETED
Enrolment	180
Start date	Sun Jan 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• H Pylori Eradication

Interventions

• Dexlansoprazole 60 mg once daily

Countries

Thailand